Home › Therapeutic areas › Neurology › Smith-Magenis Syndrome
Smith-Magenis Syndrome (1 companies)
Companies with an active program in Smith-Magenis Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | $231M | 27 |
No companies match.